Role of ganaton in antiemetic therapy. New treatment capacities
The practical introduction of new effective drugs for the prevention and treatment of nausea and vomiting is one of the important constitu- ents of maintenance therapy in cancer patients, which helps maintain a good quality of life during drug treatment. This paper considers the main mechanisms of o...
Saved in:
Main Authors: | , |
---|---|
Format: | Article |
Language: | Russian |
Published: |
ABV-press
2014-08-01
|
Series: | Опухоли женской репродуктивной системы |
Subjects: | |
Online Access: | https://ojrs.abvpress.ru/ojrs/article/view/269 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1839571004677947392 |
---|---|
author | A. V. Snegovoy L. V. Manzyuk |
author_facet | A. V. Snegovoy L. V. Manzyuk |
author_sort | A. V. Snegovoy |
collection | DOAJ |
description | The practical introduction of new effective drugs for the prevention and treatment of nausea and vomiting is one of the important constitu- ents of maintenance therapy in cancer patients, which helps maintain a good quality of life during drug treatment. This paper considers the main mechanisms of occurrence of nausea and vomiting and current recommendations for their prevention and gives the results of the authors’ studies evaluating the use of ganaton, a D2-receptor antagonist, alone and in combination with 5-HT3-receptor antagonists for the prevention and treatment of acute and delayed nausea and vomiting. The drug has shown a high efficacy and it is recommended for clinical application. |
format | Article |
id | doaj-art-d2aa9150d2f14bc6bb4da15cb5c4d0bc |
institution | Matheson Library |
issn | 1994-4098 1999-8627 |
language | Russian |
publishDate | 2014-08-01 |
publisher | ABV-press |
record_format | Article |
series | Опухоли женской репродуктивной системы |
spelling | doaj-art-d2aa9150d2f14bc6bb4da15cb5c4d0bc2025-08-04T14:33:38ZrusABV-pressОпухоли женской репродуктивной системы1994-40981999-86272014-08-0104495310.17650/1994-4098-2010-0-4-49-53285Role of ganaton in antiemetic therapy. New treatment capacitiesA. V. Snegovoy0L. V. Manzyuk1N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, MoscowN.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, MoscowThe practical introduction of new effective drugs for the prevention and treatment of nausea and vomiting is one of the important constitu- ents of maintenance therapy in cancer patients, which helps maintain a good quality of life during drug treatment. This paper considers the main mechanisms of occurrence of nausea and vomiting and current recommendations for their prevention and gives the results of the authors’ studies evaluating the use of ganaton, a D2-receptor antagonist, alone and in combination with 5-HT3-receptor antagonists for the prevention and treatment of acute and delayed nausea and vomiting. The drug has shown a high efficacy and it is recommended for clinical application.https://ojrs.abvpress.ru/ojrs/article/view/269antiemeticsnauseavomitingd2-antagonistsemetogenic complications5-ht3 and nk1-receptor antagonists |
spellingShingle | A. V. Snegovoy L. V. Manzyuk Role of ganaton in antiemetic therapy. New treatment capacities Опухоли женской репродуктивной системы antiemetics nausea vomiting d2-antagonists emetogenic complications 5-ht3 and nk1-receptor antagonists |
title | Role of ganaton in antiemetic therapy. New treatment capacities |
title_full | Role of ganaton in antiemetic therapy. New treatment capacities |
title_fullStr | Role of ganaton in antiemetic therapy. New treatment capacities |
title_full_unstemmed | Role of ganaton in antiemetic therapy. New treatment capacities |
title_short | Role of ganaton in antiemetic therapy. New treatment capacities |
title_sort | role of ganaton in antiemetic therapy new treatment capacities |
topic | antiemetics nausea vomiting d2-antagonists emetogenic complications 5-ht3 and nk1-receptor antagonists |
url | https://ojrs.abvpress.ru/ojrs/article/view/269 |
work_keys_str_mv | AT avsnegovoy roleofganatoninantiemetictherapynewtreatmentcapacities AT lvmanzyuk roleofganatoninantiemetictherapynewtreatmentcapacities |